Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/CyhgS9ncEGk/239916.php
Friday, 6 January 2012
Treating Liver Cancer With Antisense Oligonucleotide
A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer. The finding might offer a new therapy for this malignancy, which kills an estimated 549,000 people worldwide annually. The animal study, by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) and at Mayo Clinic, focused on microRNA-221 (miR-221), a molecule that is consistently present at abnormally high levels in liver cancer...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment